9-xylosyladenine has been researched along with Leukemia, Erythroblastic, Acute in 1 studies
9-xylosyladenine: RN given refers to cpd with unspecified isomeric designation; structure in first source
Leukemia, Erythroblastic, Acute: A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.
Excerpt | Relevance | Reference |
---|---|---|
"Friend virus-transformed mouse erythroleukemia (MEL) cells can be induced to undergo erythroid differentiation by a variety of compounds, including dimethyl sulfoxide (DMSO) and the adenosine analog xylosyladenine." | 1.27 | Modulation of cyclic AMP levels and differentiation by adenosine analogs in mouse erythroleukemia cells. ( Kufe, DW; Shafman, TD; Sherman, ML, 1988) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sherman, ML | 1 |
Shafman, TD | 1 |
Kufe, DW | 1 |
1 other study available for 9-xylosyladenine and Leukemia, Erythroblastic, Acute
Article | Year |
---|---|
Modulation of cyclic AMP levels and differentiation by adenosine analogs in mouse erythroleukemia cells.
Topics: Adenosine; Animals; Cell Differentiation; Cell Division; Cell Survival; Cyclic AMP; Dimethyl Sulfoxi | 1988 |